Sun, February 2, 2025
Sat, February 1, 2025
Fri, January 31, 2025
Thu, January 30, 2025
[ Thu, Jan 30th ]: Politico
RFK Jr.'s health tech fix

Danaher's (NYSE:DHR) Q4 Sales Beat Estimates

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. /danaher-s-nyse-dhr-q4-sales-beat-estimates.html
  Print publication without navigation Published in Science and Technology on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Diversified science and technology company Danaher (NYSE:DHR) in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per share was 1.3% below analysts' consensus estimates.
Danaher Corporation reported its Q4 earnings, surpassing Wall Street's sales estimates. The company, known for its diversified technology platform, achieved sales of $6.4 billion, which was above the expected $6.37 billion. Despite this, Danaher's adjusted earnings per share came in at $2.09, slightly below the anticipated $2.18. The company's performance was bolstered by strong demand in its life sciences and diagnostics segments, although it faced challenges from reduced demand in its environmental and applied solutions sector. Additionally, Danaher announced a restructuring plan aimed at improving operational efficiency and reducing costs, which includes layoffs and site consolidations. This plan is expected to yield annual savings of approximately $725 million by 2026.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/companies/danaher-s-nyse-dhr-q4-sales-beat-estimates/ar-AA1ycmIQ ]